A robust gene signature for the prediction of early relapse in stage I-III colon cancer-Reference-Cited by-同舟云学术

A robust gene signature for the prediction of early relapse in stage I-III colon cancer

Published:2018-02-16 Issue:4 Volume:12 Page:463-475
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Dai Weixing¹²,Li Yaqi¹²,Mo Shaobo¹²,Feng Yang¹²,Zhang Long³,Xu Ye¹²,Li Qingguo¹²,Cai Guoxiang¹²

Affiliation:

1. Department of Colorectal Surgery; Fudan University Shanghai Cancer Center; China

2. Department of Oncology; Shanghai Medical College; Fudan University; China

3. Shanghai Medical College; Collaborative Innovation Center of Cancer Medicine; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Fudan University; China

Funder

National Key R&D Program of China

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shanghai Shenkang Program

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference49 articles.

1. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer;Alexopoulou;Clin Biochem,2013

2. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration;Altman;PLoS Med,2012

3. From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer;Bathe;Genes,2014

4. Surgery of colorectal carcinoma;Becker;Praxis,1995

5. Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer;Berghella;Cancer Biother Radiopharm,2002

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable machine learning model identified potential biomarkers in liver cancer survival prediction;Biomedical Signal Processing and Control;2024-10

2. Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer;2024-08-08

3. RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco;Cancer Control;2024-01

4. Identification of Necroptosis-related Subtypes and Characterization of Tumor Microenvironment Infiltration in Non-small Cell Lung Cancer;Current Cancer Drug Targets;2024-01

5. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer;Current Medicinal Chemistry;2023-11-02